151 related articles for article (PubMed ID: 22197436)
21. Integrin β4 is a major target antigen in pure ocular mucous membrane pemphigoid.
Li X; Qian H; Sogame R; Hirako Y; Tsuruta D; Ishii N; Koga H; Tsuchisaka A; Jin Z; Tsubota K; Fukumoto A; Sotozono C; Kinoshita S; Hashimoto T
Eur J Dermatol; 2016 Jun; 26(3):247-53. PubMed ID: 27193492
[TBL] [Abstract][Full Text] [Related]
22. Direct Immunofluorescence Findings and Factors Affecting Conjunctival Biopsy Positivity in Ocular Mucous Membrane Pemphigoid.
Jain N; Jakati S; Shanbhag SS; Basu S
Cornea; 2024 Feb; 43(2):159-165. PubMed ID: 37699562
[TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid.
Labowsky MT; Stinnett SS; Liss J; Daluvoy M; Hall RP; Shieh C
Am J Ophthalmol; 2017 Nov; 183():48-55. PubMed ID: 28860044
[TBL] [Abstract][Full Text] [Related]
24. Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid.
Shimanovich I; Nitz JM; Zillikens D
J Am Acad Dermatol; 2017 Oct; 77(4):700-705.e3. PubMed ID: 28676329
[TBL] [Abstract][Full Text] [Related]
25. Low pH condition impairs BP-IgG binding to the basement membrane zone.
Im D; Ueda K; Niwa H; Tanaka K; Iwata H
J Dermatol; 2024 May; 51(5):643-648. PubMed ID: 38482975
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
27. Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines.
Mohimen A; Neumann R; Foster CS; Ahmed AR
Curr Eye Res; 1993 Aug; 12(8):741-52. PubMed ID: 8222735
[TBL] [Abstract][Full Text] [Related]
28. Desquamative gingivitis associated with IgG/IgA pemphigoid presents a challenging diagnosis and treatment: a case report.
Sánchez AR; Rogers RS; Kupp LI; Sheridan PJ
J Periodontol; 2004 Dec; 75(12):1714-9. PubMed ID: 15732876
[TBL] [Abstract][Full Text] [Related]
29. Collagen abnormalities in conjunctiva of patients with cicatricial pemphigoid.
Dutt JE; Ledoux D; Baer H; Foster CS
Cornea; 1996 Nov; 15(6):606-11. PubMed ID: 8899273
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of IL8 pathway on the ocular surface: new insights in patients with ocular mucous membrane pemphigoid.
Bruscolini A; Lambiase A; Segatto M; La Cava M; Nebbioso M; Sacchetti M
Acta Ophthalmol; 2020 Mar; 98(2):e173-e177. PubMed ID: 31486595
[TBL] [Abstract][Full Text] [Related]
31. Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid.
Thorne JE; Anhalt GJ; Jabs DA; de la Cruz Z; Green WR
Ophthalmology; 2006 Sep; 113(9):1651-6. PubMed ID: 16828515
[TBL] [Abstract][Full Text] [Related]
32. Vortex Keratopathy as a Presenting Feature of Ocular Mucous Membrane Pemphigoid.
Singh C; Jain N; Sharma S; Basu S; Shanbhag SS
Cornea; 2023 Nov; 42(11):1454-1457. PubMed ID: 37318153
[TBL] [Abstract][Full Text] [Related]
33. Ocular cicatricial pemphigoid: case report.
Louie TD
J Am Optom Assoc; 1998 Mar; 69(3):153-60. PubMed ID: 9553330
[TBL] [Abstract][Full Text] [Related]
34. Mucous membrane pemphigoid affecting the oral cavity: short review on etiopathogenesis, diagnosis and treatment.
Petruzzi M
Immunopharmacol Immunotoxicol; 2012 Jun; 34(3):363-7. PubMed ID: 22564172
[TBL] [Abstract][Full Text] [Related]
35. Erosive lichen planus of the vulva: weak circulating basement membrane zone antibodies are present.
Cooper SM; Dean D; Allen J; Kirtschig G; Wojnarowska F
Clin Exp Dermatol; 2005 Sep; 30(5):551-6. PubMed ID: 16045691
[TBL] [Abstract][Full Text] [Related]
36. Ocular cicatricial pemphigoid occurring as a sequela of Stevens-Johnson syndrome.
Chan LS; Soong HK; Foster CS; Hammerberg C; Cooper KD
JAMA; 1991 Sep; 266(11):1543-6. PubMed ID: 1880886
[TBL] [Abstract][Full Text] [Related]
37. Exacerbation of undiagnosed ocular cicatricial pemphigoid after repair of involutional entropion.
Hatton MP; Raizman M; Foster CS
Ophthalmic Plast Reconstr Surg; 2008; 24(2):165-6. PubMed ID: 18356734
[TBL] [Abstract][Full Text] [Related]
38. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of anti-laminin 5 mucous membrane pemphigoid.
Rose C; Schmidt E; Kerstan A; Thoma-Uszynski S; Wesselmann U; Käsbohrer U; Zillikens D; Shimanovich I
J Am Acad Dermatol; 2009 Sep; 61(3):433-40. PubMed ID: 19700013
[TBL] [Abstract][Full Text] [Related]
40. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
